Molecules (Nov 2022)

Development and Validation of an LC-MS/MS Method for Simultaneous Determination of Short Peptide-Based Drugs in Human Blood Plasma

  • Elizaveta N. Fisher,
  • Evgeny S. Melnikov,
  • Vladimir Gegeckori,
  • Natalya V. Potoldykova,
  • Dmitry V. Enikeev,
  • Kirill A. Pavlenko,
  • Snezana Agatonovic-Kustrin,
  • David W. Morton,
  • Galina V. Ramenskaya

DOI
https://doi.org/10.3390/molecules27227831
Journal volume & issue
Vol. 27, no. 22
p. 7831

Abstract

Read online

A novel HPLC-ESI-MS/MS method for simultaneous gonadotropin-releasing hormone (GnRH) analogs and somatostatin analog quantitation was developed and validated. The developed method was successfully applied to pharmacokinetic studies. The sample preparation process included solid-phase extraction (SPE). Effective chromatographic separation of the analytes and internal standard (dalargin) was achieved with a C18 column, using a gradient elution with two mobile phases: 0.1% v/v formic acid (aqueous solution) and 0.1% v/v formic acid (acetonitrile solution). The linearity of the method was demonstrated within a concentration range of 0.5–20 ng/mL, with correlation coefficients between 0.998–0.999 for goserelin, buserelin, triptorelin, and octreotide, respectively. The relative standard deviation (RSD, %) values for method accuracy and precision did not exceed 20% at the lower level of quantitation (LLOQ) or 15% at other concentration levels.

Keywords